The results from this study demonstrate that loss of membranous ezrin expression in urothelial bladder cancer is strongly associated with a more aggressive tumour phenotype; i.e. higher grade and more advanced tumour stage, and an impaired survival. Here, EZR is linked to bladder transitional cell carcinoma.